WebDr. Jeanny Aragon-Ching, MD is an Oncology Specialist in Fairfax, VA and has over 26 years of experience in the medical field. Dr. Aragon-Ching has extensive experience in Renal … WebMar 10, 2024 · Sam Chang and Jeanny Aragon-Ching discuss treatment and survival differences in patients with urothelial versus non-urothelial bladder and upper tract carcinomas an analysis from the National Cancer Database (NCDB). There is an increased need for learning more about urothelial and non-urothelial cancers because non-urothelial …
ICMJE DISCLOSURE FORM
WebA member of Inova Medical Group Specialty: Medical Oncology, Internal Medicine Clinical Interests: Blood Disorders, Breast Cancer, Cancer, Lung Cancer Years of Experience: 38 Bhavisha Patel, MD A member of Inova Medical Group Specialty: Medical Oncology, Hematology, Internal Medicine Years of Experience: 13 Danielle A. Shafer, DO WebDr. Jeanny Aragon-Ching, MD, is an Oncology specialist practicing in FAIRFAX, VA with 26 years of experience. This provider currently accepts 53 insurance plans including … butch ream
Dr. Jeanny Aragon-Ching, MD, Oncology FAIRFAX, VA
WebOct 28, 2015 · Jeanny Aragon-Ching, MD, FACP, is a nationally recognized genitourinary (GU) medical oncologist with particular expertise in prostate, bladder, and kidney cancers. At ISCI, Dr. Aragon-Ching serves ... Web(UroToday.com) The 2024 ESMO annual meeting featured a urothelial cancer session, including a presentation by Dr. Jeanny Aragon-Ching discussing extended results of JAVELIN Bladder 100 for patients receiving ≥12 months of Avelumab first-line maintenance for advanced urothelial carcinoma. WebJun 7, 2024 · Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile. cd8 vs cd45